EP Patent

EP2461795A2 — Sublingual and buccal film compositions

Assigned to Indivior UK Ltd · Expires 2012-06-13 · 14y expired

What this patent protects

The present invention relates to products and methods for treatment of narcotic dependence in a user. The invention more particularly relates to self- supporting dosage forms which provide an active agent for treating narcotic dependence while providing sufficient buccal adhesion…

USPTO Abstract

The present invention relates to products and methods for treatment of narcotic dependence in a user. The invention more particularly relates to self- supporting dosage forms which provide an active agent for treating narcotic dependence while providing sufficient buccal adhesion of the dosage form.

Drugs covered by this patent

Patent Metadata

Patent number
EP2461795A2
Jurisdiction
EP
Classification
Expires
2012-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Indivior UK Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.